Guardian Point Capital, LP Infinity Pharmaceuticals, Inc. Transaction History

Guardian Point Capital, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $2.23 Million - $4.03 Million	-1,200,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $2.38 Million - $6.43 Million	1,200,000 New	1,200,000 $3.88 Million

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Guardian Point Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Point Capital, LP with notifications on news.